| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.047 | 0.4 |